Pharma news
Pharma
Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici. 1 July 2020
Pharma
The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be. 26 June 2020
Pharma
The English Court of Appeal has rejected Neurim’s attempt to block sales of a generic version of its insomnia drug made by Mylan ahead of a patent infringement trial. 26 June 2020
Americas
Gilead Sciences has begun a potential takeover of Pionyr Immunotherapeutics after it agreed to pay $275 million for a 49.9% equity stake in the cancer research company. 25 June 2020
Pharma
The CJEU’s many attempts to clarify the law around SPCs has created more questions than answers, as Katie Cambrook and Ben Millson of Bristows explain. 23 June 2020
Pharma
The European Commission has backed voluntary IP licensing as part of its new vaccines strategy. 18 June 2020
Pharma
Switzerland-based Novartis has failed to convince the UK Intellectual Property Office that a trademark applied-for by Boston Healthcare should not be registered. 18 June 2020
Pharma
The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners. 16 June 2020
Americas
The US Supreme Court has declined to review Eli Lilly’s patent infringement victory against Dr Reddy’s and Hospira. 16 June 2020
Americas
A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs. 11 June 2020